Society ❯ Women's Rights ❯ Healthcare Access ❯ Legal Issues

State Regulations

FDA Opens Mifepristone Safety Review as 20 States Vow to Defend Access

Experts say any changes are likely to target telehealth and mail distribution rather than revoke approval.